期刊
CLINICAL AND TRANSLATIONAL MEDICINE
卷 12, 期 8, 页码 -出版社
JOHN WILEY & SONS LTD
DOI: 10.1002/ctm2.1021
关键词
autophagy deficiency; chronic rhinosinusitis; eosinophilic inflammation; IL-1 beta; macrophage; sweet taste receptor
资金
- National Research Foundation of Korea [2019R1A2C2006475, 2019R1C1C1009705, 2022R1F1A1074419, 2018R1A5A2020732]
- Korea Health Industry Development Institute [HI21C1568]
- Asan Institute for Life Sciences, Asan Medical Center [2021IP0003, 2021IL0013]
- National Research Foundation of Korea [2019R1A2C2006475, 2019R1C1C1009705, 2022R1F1A1074419] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
This study found that sweet taste receptor agonists such as trehalose and saccharin have anti-inflammatory effects and can alleviate the occurrence of refractory chronic rhinosinusitis. Trehalose can reduce the production of IL-1 beta in macrophages, thereby alleviating the inflammatory pathogenesis.
Background: Eosinophilic inflammation is a hallmark of refractory chronic rhinosinusitis (CRS) and considered a major therapeutic target. Au tophagy deficiency in myeloid cells plays a causal role in eosinophilic CRS (ECRS) via macrophage IL-1 beta overproduction, thereby suggesting autophagy regulation as a potential therapeutic modality. Trehalose is a disaccharide sugar with known pro-autophagy activity and effective in alleviating diverse inflammatory diseases. We sought to investigate the therapeutic potential of autophagy-enhancing agent, trehalose, or related sugar compounds, and the underlying mechanism focusing on macrophage IL-1 beta production in ECRS pathogenesis. Methods: We investigated the therapeutic effects of trehalose and saccharin on macrophage IL-1 beta production and eosinophilia in the mouse model of ECRS with myeloid cell-specific autophagy-related gene 7 (Atg7) deletion. The mechanisms underlying their anti-inflammatory effects were assessed using specific inhibitor, genetic knockdown or knockout, and overexpression of cognate receptors. Results: Unexpectedly, trehalose significantly attenuated eosinophilia and disease pathogenesis in ECRS mice caused by autophagy deficiency in myeloid cells. This autophagy-independent effect was associated with reduced macrophage IL-1 beta expression. Various sugars recapitulated the anti-inflammatory effect of trehalose, and saccharin was particularly effective amongst other sugars. The mechanistic study revealed an involvement of sweet taste receptor (STR), especially T1R3, in alleviating macrophage IL-1 beta production and eosinophilia in CRS, which was supported by genetic depletion of T1R3 or overexpression of T1R2/T1R3 in macrophages and treatment with the T1R3 antagonist gurmarin. Conclusion: Our results revealed a previously unappreciated anti-inflammatory effect of STR agonists, particularly trehalose and saccharin, and may provide an alternative strategy to autophagy modulation in the ECRS treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据